ENVOY MEDICAL, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-6.0M | $-4.4M | $-6.5M | $-5.7M | $-5.0M | $-6.0M | $-3.9M | $-6.3M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $74.0K | $73.0K | $76.0K | $85.0K | $61.0K | $49.0K | — | $34.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $239.0K | — | — | $160.0K | — | — | $123.0K |
| Net Cash from Operating Activities | $-5.5M | $-6.1M | $-4.3M | $-4.5M | $-3.7M | $-2.6M | $-4.6M | $-5.6M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | $0 | $1.0K | $6.0K | $1.2M | $248.0K | $109.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | $-6.0K | — | — | $-109.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | $1.2M | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $27.6M | — | — | $3.6M | — | — | $6.4M |
| Net Change in Cash | — | $21.5M | — | — | $-171.0K | — | — | $727.0K |
| Free Cash Flow | — | — | $-4.3M | $-4.5M | $-3.7M | $-3.8M | $-4.9M | $-5.7M |